QA: Ernexa Therapeutics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000748592_2023_Ernexa_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000748592, Ernexa Therapeutics Inc

  xvar xval
0 AssetsCurrent 13,681,000
1 IntangibleAssetsNetIncludingGoodwill 2,044,000
2 PropertyPlantAndEquipmentNet 236,000
3 remainder_Assets 6,318,000
4 LiabilitiesCurrent 7,654,000
5 LiabilitiesNoncurrent 981,000
6 remainder_Liabilities 1,537,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,632,037
9 ResearchAndDevelopmentExpense 10,748,308
10 remainder_Expenses 85,405,084
11 remainder_Revenues 0
12 remainder_NetIncome -8,740,648
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 22,279,000
1 Liabilities 10,172,000
2 Expenses 112,785,429
3 Revenues 0
4 StockholdersEquity 12,107,000
5 NetIncome -121,526,077
6 ComprehensiveNetIncome -121,526,077
7 BaseVar 76,988,538
8 EconomicCapitalRatiobeforeLimitedLiability -5.86
9 EconomicCapitalRatio 0.0902

Edgar->Model Mapping

Feature Distribution

Change over Time